These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9445137)

  • 1. Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations.
    Konomoto T; Fukuda T; Hayashi K; Kumazawa J; Tsuneyoshi M
    Hum Pathol; 1998 Jan; 29(1):74-81. PubMed ID: 9445137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
    Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
    Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma.
    She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P
    Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas.
    O'Reilly PE; Raab SS; Niemann TH; Rodgers JR; Robinson RA
    Mod Pathol; 1997 Feb; 10(2):91-7. PubMed ID: 9127313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy.
    Schneider-Stock R; Radig K; Oda Y; Mellin W; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(4):211-8. PubMed ID: 9177493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors analysis of Ki-67, α-SMA expression in retroperitoneal leiomyosarcoma].
    Ma C; Li PY; Zhang N; Sun CB; Hou L; Liu N
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):258-263. PubMed ID: 29730911
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R; Bracko M; Novak J
    Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
    Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
    J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior.
    Oshiro Y; Shiratsuchi H; Oda Y; Toyoshima S; Tsuneyoshi M
    Mod Pathol; 2000 Nov; 13(11):1211-8. PubMed ID: 11106079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor genes and related molecules in leiomyosarcoma.
    Dei Tos AP; Maestro R; Doglioni C; Piccinin S; Libera DD; Boiocchi M; Fletcher CD
    Am J Pathol; 1996 Apr; 148(4):1037-45. PubMed ID: 8644845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas.
    Zhai YL; Kobayashi Y; Mori A; Orii A; Nikaido T; Konishi I; Fujii S
    Int J Gynecol Pathol; 1999 Jan; 18(1):20-8. PubMed ID: 9891238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
    Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
    Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
    Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
    Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.